Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Related Articles


ISCHEMIA Trial: Key Questions and Answers

José López-Sendón, Raul Moreno, Juan Tamargo,


Citation: European Cardiology Review 2021;16:e34.

TAVI in Challenging Scenarios

Sandra Santos-Martínez, Ignacio J Amat-Santos,


Citation: European Cardiology Review 2021;16:e29.

Patient-specific Computer Simulation of Bicuspid Aortic Valve

Cameron Dowling, Robert Gooley, Liam McCormick,


Citation: Interventional Cardiology 2021;16:e26.

Unknown Risks of Transplantation in Adults with Congenital Heart Disease

Aniket S Rali, Angela Weingarten, Emily Sandhaus,


Citation: Cardiac Failure Review 2021;7:e14.